Axogen Inc vs Blackstone Inc — how do they compare? Axogen Inc trades at $38.5 (market cap $2.06B), while Blackstone Inc trades at $126.21 (market cap $152.15B). The key difference: Blackstone Inc is far larger — about 73.9× Axogen Inc's market cap, and Blackstone Inc pays a 3.99% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| AXGN | BX | |
|---|---|---|
Market Cap | $2.06B | $152.15B |
Sector | Technology | Financials |
52-Week High | $46.19 | $188.68 |
52-Week Low | $11.28 | $102.12 |
Enterprise Value | $1.98B | — |
Dividend Yield | — | 3.99% |
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Blackstone (BX) trades at $122.06, down 0.83% today, with a bullish technical signal and strong analyst support. Recent earnings beats and a 24.27% net income margin highlight robust profitability, while a $5.34 billion AI infrastructure deal with Williams underscores strategic growth. The stock faces resistance near $123 with support at $121.
Outlook remains positive given consistent earnings outperformance and institutional bullishness, though valuation multiples like a P/E of 31.29 pose risks if growth slows. Key opportunities include AI-driven investments, while macroeconomic volatility and high leverage are concerns.
Trailing returns across standard periods
Latest headlines on both assets
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →Blackstone is one of the world's largest alternative asset managers with $940.8 billion in total asset under management, including $683.8 billion in fee-earning asset under management, at the end of June 2022.
Read more on BX →